[1] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志,2013,16(3):210-216. [2] Chuang CS,Tung SY,Lee IL,et a1.Clinical features and outcome of chronic viral hepatitis with acute exacerbation in patients with concurrent infections of hepatitis B and C virus.Dig Dis Sei,2008,53(2):511-516. [3] Wang YM,Tang YZ.Antiviral therapy for hepatitis B vires associated hepatic failure.Hepatobiliary Pancreat Dis Int,2009,8 (1):17-24. [4] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [5] 中华传染病与寄生虫病学会人工肝学组.人工肝支持系统的适应证,禁忌证及疗效判断标准.中华肝脏病杂志,2005,13(6):405-407. [6] 中华医学会感染病学分会肝功能衰竭与人工肝学组.非生物型人工肝支持系统治疗肝功能衰竭指南(2009年版). 中华临床感染病杂志,2009,6(2):321-325. [7] Kobayashi N. Life support of artificial liver:development of a bioartificial fiver to treat liver failure.J Hepatobiliary Pancreat Surg,2009,16(4):113-117. [8] Nishimura A,Umehara Y,Umehara M,et a1. Plasma exchange based plasma recycling dialysis system as a potential platform for artificial liver support.Artif Organs,2006,30:629-633. [9] Zhang XQ,Jiang L,You JP,et al. Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure. Hepatol Res,2011,41(1):46-53. [10] Hessel FP,Bramlage P,Wasem J,et al. Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol,2010,22(2):213-220. |